Global antibodies industry data book is a collection of market sizing information & forecasts, regulatory data, competitive benchmarking analyses, macro-environmental analyses, and technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.
The antibodies industry data book is a combination of the market data from seven reports namely, antibodies production, polyclonal antibodies, monoclonal antibodies, cancer monoclonal antibodies, research antibodies, custom antibodies, and mammalian polyclonal IgG antibodies market. Antibody Production Market Growth & Trends The antibodies industry has observed tremendous growth in the last couple of decades. There has been continuous advancement in the manufacturing technologies that are being implemented in producing these novel biologics. With the discovery of applications of polyclonal and monoclonal antibodies for research purposes as well as therapeutic purposes, the demand for antibodies production has increased exponentially. A large number of companies as well as CDMOs are involved in the manufacturing of antibodies at the commercial scale. The use of single-use technology such as single-use assemblies and single-use bioreactors has also played a crucial role in reducing the processing cost and boosting the production scale, thus pushing the antibodies production market growth. With major pharmaceutical key players investing in the manufacturing processes, the global market for antibodies production is likely to exhibit exponential growth in the forthcoming years. The outbreak of COVID-19 has created lucrative opportunities in this business. Several leading pharmaceutical companies are investing heavily in R&D to create brand-new vaccinations, treatments, and testing tools for this pandemic. The need for antibodies production has greatly increased as a result of these intense R&D operations for the development of novel therapeutics. Additionally, a number of public and commercial entities are making significant efforts to fund the development of COVID-19 vaccines and therapeutics. For instance, in April 2020, Emergent BioSolutions, a biopharmaceutical company, received USD 14.5 million from the federal government to work on an antibodies therapy study for COVID-19. Monoclonal Antibodies Market Analysis & Forecast In this market, the oncology segment led the global market in 2022 and accounted for a revenue share of more than 35%. Monoclonal antibodies are being used extensively for the treatment of various cancers. Some of the major types of cancers being treated with mAbs include blood cancer, breast cancer, and lung cancer. These indications collectively take up more than half of the oncology segment of this market. Cancer is a class of chronic diseases categorized by uncontrolled cell growth. The increasing number of cancer cases is anticipated to increase the demand for monoclonal antibodies and propel market growth. According to the American Society of Clinical Oncology, by the end of 2022, there will be a projected 1.9 million diagnosed cancer cases and 609,360 deaths in the U.S. In addition, the estimates by the same source projected that in 2020, an estimated 176,000 people globally were diagnosed with multiple myeloma. In 2022, it is projected that more than 34,000 individuals will be diagnosed with multiple myeloma, and above 12,000 people will die in the U.S. Research Antibodies Market Analysis & Forecast In the research antibodies market, the rabbit source segment held the largest market share of 50.2% in 2022. Rabbits are regularly used for antibodies production, due to various advantages including higher affinity antibodies provided by rabbits as compared to those obtained from other animal hosts. Furthermore, rabbit-sourced antibodies offer higher specificity which makes them ideal for the detection of small molecules, hormones, and toxins among others. The mouse source segment is anticipated to witness considerable growth over the forecast period. Mice have been predominantly used in the production of antibodies due to their high reproduction rate and smaller size. Furthermore, the main factor influencing their widespread use is the structural similarity between mouse and human antibodies, which can significantly drive their adoption for R&D applications. Major market players such as Abcam Plc., Merck KGaA, Thermo Fisher Scientific, Inc., and Cell Signaling Technology, Inc. have been continuously involved in the development of products and exploring new application areas for research antibodies. Order your copy of Free Sample of “Antibodies Industry Data Book - Antibodies Production, Polyclonal Antibody, Monoclonal Antibody, Cancer Monoclonal Antibody, Research Antibody, Custom Antibody, Mammalian IgG Polyclonal Antibody Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Competitive Landscape Key players operating in the Antibodies Industry are – • Danaher Corporation • Thermo Fisher Scientific Inc. • Sartorius AG • GE Healthcare • Eppendorf AG • Merck KGaA • Amgen Inc • Novartis AG • AstraZeneca plc • Abcam plc • F. Hoffman-La Roche Ltd. • Eli Lilly and Company
0 Comments
Global API and High Potency API industry databook is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.The following data points will be included in the final product offering in two reports and one sector report overview.
The global active pharmaceutical ingredients market was valued at USD 209.71 billion in 2021 and is anticipated to witness growth at a rate of 5.9% over the forecast period. The global high potency API market was valued at USD 23.60 billion in 2021 and is anticipated to witness growth at a rate of 6.2% over the forecast period. Active Pharmaceutical Ingredients Market Growth & Trends The global active pharmaceutical ingredients market was valued at USD 209.71 billion in 2021 and is anticipated to witness growth at a rate of 5.9% over the forecast period. The Active Pharmaceutical Ingredients market is becoming more competitive and consumer needs are becoming highly focused toward efficacy & specificity of therapeutic agent raw material. Buyers tend to purchase materials matching their requirements and negotiate the price. Thus, buyers are highly involved in the purchasing process to ensure quality of material matches their requirement. High capital is required for production of APIs because the process needs extremely systematic protocols, which leads to increase in outsourcing of various API production processes. Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer. For instance, in November 2022, Novo Nordisk spent USD 747 million for expanding its API manufacturing facility in Denmark, in November 2022, GE Healthcare invested USD 80 million for expanding its API manufacturing site in Norway. Companies that have been outsourcing API manufacturing to China to reduce costs are now aiming toward switching to other countries and are looking for backward integration. This is creating growth opportunities for other leading API-producing countries, such as India, to increase market shares in the changing market scenario. Innovative Active Pharmaceutical Ingredients market dominated the market with a revenue share of 53.5% in 2021. Favorable regulations for R&D facilities and increase in funding are key factors driving the innovative Active Pharmaceutical Ingredients market. Owing to extensive research in this field, many novel innovative products are now in pipeline and are expected to be launched over the forecast period. New entrants in this segment are expected to drive the market. An example of a market player engaged in extensive R&D is Lonza, with more than 575 clinical development programs in 2018. Oncology is a leading domain for high-potency innovative API products due to need for low dosage and fewer adverse effects. Thus, highest percentage of HPAPIs is used in anticancer drugs. These APIs have also found application in hormonal imbalance, cardiovascular, musculoskeletal, and CNS drugs as well as in treatment of glaucoma. Order your copy of Free Sample of “Active Pharmaceutical Ingredients and High Potency API Industry Data Book - Active Pharmaceutical Ingredients and High Potency Active Pharmaceutical Ingredients Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research High Potency Active Pharmaceutical Ingredients Market Growth & Trends The global high potency API market was valued at USD 23.60 billion in 2021 and is anticipated to witness growth at a rate of 6.2% over the forecast period. HPAPIs are attracting generic manufacturers’ attention due to patent expiry of blockbuster drugs. Moreover, CDMOs are constantly coming up with lower Occupational Exposure Limits (OELs) for intermediates and materials, which ensures employee safety. For addressing the unmet medical needs, companies are collaborating to develop novel High Potency Active Pharmaceutical Ingredients (HPAPIs). This allows firms to use their resources to aid the development of products and enhance their supply chain. For instance, in January 2022, Lonza, BioGeneration Ventures (BGV), and Forbion announced the extension of their collaboration to include development & production of small molecules (biologics). Lonza will provide customized services to BGV and Forbion’s large molecule biologic portfolio. Captive high potencyAPI manufacturing market segment is anticipated to hold high revenue share. Outsourced market segment is driven by factors such as rising demand for biopharmaceuticals and growing cost of manufacturing these molecules in-house. Moreover, dual sourcing is becoming a key strategy and increasingly being adopted by these companies. HPAPI molecules are manufactured by some pharmaceutical companies at in-house manufacturing facilities. Pharmaceutical companies invest heavily to develop in-house capabilities and specialized requirements for toxicity containment. According to Japan Pharmaceutical Manufacturers Association, Japanese pharmaceutical companies have continuously increased their investments in R&D for discovery and development of novel drugs every year. These investments represent more than 17% of total net sales. These companies have also launched their own research funds to collaborate with outside researchers to develop new drugs. For example, a3 (a-cube) and TaNeDS launched by Astellas Pharma and Daiichi Sankyo, respectively. Competitive Landscape Key players operating in the Active Pharmaceutical Ingredients and High Potency API Industry are – • Novo Nordisk • Merck KGaA • Novartis AG • Aurobindo Pharma • Piramal Pharma • Teva Pharmaceutical Industries Ltd. • AbbVie, Inc. • BASF SE • Boehringer Ingelheim International GmbH • CordenPharma • Merck & Co., Inc. • Dr. Reddy’s Laboratories Ltd. • Cipla, Inc. • Bristol-Myers Squibb Company • Sun Pharmaceutical Industries Ltd. • Sanofi • Pfizer, Inc. • Viatris Inc. • Albemarle Corporation • Aurobindo Pharma Global life science microscopes Industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. The global life science microscopes industry generated over USD 3.35 billion in 2021 and is expected to grow at a CAGR of 8.9% over the forecast period. Surgical Microscopes Market Growth & Trends The global surgical microscopes market was valued at USD 1.10 billion in 2021 and is anticipated to witness growth at a rate of 11.37% over the forecast period. Complex minimally invasive neurosurgery and ENT procedures demand more precision from the surgeons performing the operations. With the advent of surgical microscopes, it became easier for surgeons to perform such procedures more accurately in less time. In addition, the introduction of technologically advanced products is driving the demand for surgical microscopes as they are more precise, offer better illumination sources, and provide options for customization and technology integration based on the complexity of the procedures. Emerging technologies such as wide-angle illumination, Red Reflex illumination, automation and augmented reality microscopy are expected to boost the demand for surgical microscopes. International players like Carl Zeiss Meditec AG and Leica Microsystems are contributing to the market by providing highly advanced, automated, and robotic surgical microscopes for more precision. The surgical microscopes market is segmented based on type, applications, and end-use. Based on type it is divided into casters, wall-mounted, tabletop, and ceiling-mounted. The on-caster microscopes held a significant share in 2021 and are anticipated to grow at the highest CAGR over the forecast period. Portability and flexibility of the devices for better adjustment during surgeries and easy maintenance are some of the key factors governing this segment's growth. In-vitro Fertilization Microscopes Market Growth & Trends The in-vitro fertilization microscopes market was valued at USD 94.03 million in 2021 and is expected to reach USD 193.3 million by 2030 at a CAGR of 8.37% from 2022 to 2030. Improving the success rate of In Vitro Fertilization (IVF) procedures and the availability of financial assistance are expected to boost the market growth. Moreover, product innovations by manufacturers are increasing treatment efficiency and are expected to reduce the procedure cost. The inverted microscope segment dominated the overall in vitro fertilization microscopes market in terms of revenue share in 2021 due to its compatibility with micromanipulators for use in Intracytoplasmic Sperm Injection (ICSI) procedures and comparatively high product cost. The stereo microscope held the second-largest revenue share due to innovations in time-lapse microscopy, reducing the time required for embryo assessment. The end-user segment is classified into clinical and academic research. The clinical segment dominated the overall in vitro fertilization microscopes market in terms of revenue share in 2021 due to factors such as increased adoption of IVF treatment. Europe dominated the in vitro fertilization microscopes market in 2021 due to factors such as growing fertility tourism, legal reforms, and product innovation. However, Asia Pacific is expected to witness the fastest growth over the forecast period owing to key factors such as increasing awareness and availability of IVF services. Order your copy of Free Sample of “Life Science Microscopes Industry Data Book - Surgical, In-vitro Fertilization, Super Resolution And Scanning Electron Microscopes Market Size, Share, Trends Analysis And Segment Forecasts, 2022 - 2030” Data Book, published by Grand View Research Super-resolution Microscopes Market Growth & Trends The global super-resolution microscopes market was valued to be USD 1.2 billion in 2021 and is expected to reach USD 2.7 billion by 2030, growing at a CAGR of 9.22% over the forecast period. Increasing demand for super-resolution microscopy in nanotechnology and its wide application in the life science industry mainly in microbiology, oncology for cancer cell proliferation, biomedical imaging, and drug discovery are the key reasons for the growth of the market. Furthermore, technological advancements in diagnostic techniques, increasing government support, and corporate funding for microscopy are a few other key factors driving the market. The Life Science application segment held the largest revenue share in 2021 owing to the growth in applications of super-resolution microscopy in the life science verticals such as molecular biology, biomedical imaging, and drug discovery. However, the nanotechnology segment is expected to grow with the fastest CAGR over the forecast period. North America accounted for the largest revenue share in 2021. This can be attributed to the significant development of technology in the U.S. and the local presence of top market leaders in the country. Various initiatives and funding to support the development of advanced technology by the U.S. government are also driving market growth in North America. Scanning Electron Microscopes Market Growth & Trends The global life science scanning electron microscope market size was valued at USD 912.02 million in 2021 and is expected to exhibit a CAGR of 7.73% during the forecast period to reach an estimated value of USD 1.79 billion by 2030. Increasing R&D activities in the field of nanotechnology & life sciences, and product innovations are some of the key factors driving the market growth. However, the high cost of scanning electron microscopes may hamper the growth of the market. Based on end users, the market is segmented into material science, nanotechnology, life science, semiconductors, and other applications. In 2021, life science dominated the market due to the availability of several products with special applications in the field of life science. However, the nanotechnology segment is expected to grow at the fastest rate during the forecast period. This can be attributed to the expected launch of technologically advanced products due to growing investments by several major players and the rising adoption of such products in emerging countries. Go through the table of content of Life Science Microscopes Industry Data Book to get a better understanding of the Coverage & Scope of the study. Competitive Landscape Key players operating in the Life Science Microscopes Industry are – • Carl Zeiss Meditec AG • Leica Microsystems • Olympus Corporation • Nikon Corporation • Applied Precision (GE Healthcare) • Haag-Streit Surgical GmbH • Synaptive Medical • Alcon, Inc. (Novartis) • Topcon Corporation • ARI Medical Technology Co., Ltd. • Takagi Seiko Co., Ltd. • Seiler Instrument Inc. • Chammed Co. Ltd Veterinary Imaging Instrument Industry: Advancing Technology From Fuzzy Scans To Precise Pictures1/3/2024 Global Veterinary Imaging Instrument industry data book is a collection of market sizing information & forecasts, regulatory data, competitive benchmarking analyses, macro-environmental analyses, and technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.
The global Veterinary Imaging Instrument Market size for the veterinary imaging instrument was estimated at USD 1.44 Billion in 2021 and is anticipated to increase at a CAGR of 5.7% from 2022 to 2030. Veterinary X-Ray Market Analysis And Forecast The global veterinary X-Ray market generated over USD 546.9 million in 2021 and is expected to grow at a CAGR of 4.0% over the forecast period. The market is driven by technological advancements in animal healthcare, which include effective assimilation of radiology information systems and teleradiology. Rising adoption in orthopedics and focus on innovation in animal health is anticipated to fuel demand. An X-ray is a typical option for imaging to diagnose problems such as cough, trauma, fever, and troubled breathing among animals. Veterinarians use radiographs to examine pneumonia, cancer, heart problems, and other disease conditions. X-rays are the oldest but most frequently used imaging modality. Key players operating in this market are Sound; IDEXX Laboratories, Inc.; FUJIFILM Holdings America Corporation; and Carestream Health. Veterinary Ultrasound Market Analysis And Forecast The global veterinary ultrasound market was valued at USD 326.7 million in 2021 and is anticipated to witness growth at a rate of 6.8% over the forecast period. Ultrasonography is the second most used veterinary imaging diagnosis. It uses ultrasound waves of 1.5 MHz to 15 MHz frequency on the body parts and creates images based on the echo pattern received from tissues. Since ultrasound equipment is non-radiographic, it is cheaper than other imaging modalities, such as CT & MRI, and easily portable. Wide applicability, ease of usage and cost-effectiveness are key attributes expected to drive the growth of this market in the near future too. Based on type, the market is segmented into 2-D ultrasound imaging, 3-D/4-D ultrasound imaging, and Doppler imaging. The 2-D ultrasound imaging segment accounted for the maximum revenue share of around 39% in 2021. The market growth is attributed to the widespread popularity of such devices in pregnancy detection as well as disease diagnosis. Furthermore, less cost as compared to other types of ultrasounds is also expected to boost the market growth. Based on scanner type, the market is segmented into cart-based ultrasound scanners and handheld scanners. The cart-based ultrasound scanners segment accounted for the maximum revenue share of more than 50% in 2021. The market growth is attributed to their high adoption due to ease of use and extensive use in veterinary clinics, hospitals, and diagnostic centres, Based on application, the market is classified into orthopedics, cardiology, oncology, obstetrics & gynaecology, and others. The cardiology segment accounted for the maximum revenue share of around 25.0% in 2021. The increasing prevalence of cardiac disorders in animals is expected to contribute to market growth. Based on end-use, the market is segmented into veterinary hospitals & clinics and others. The hospitals & clinics segment accounted for the highest revenue share of more than 55% in 2021. The availability of a wide range of diagnostic alternatives in hospitals and clinics is anticipated to contribute to market growth. Order your copy of Free Sample of “Veterinary Imaging Instrument Industry Data Book - Veterinary X-Ray, Veterinary Ultrasound, Animal MRI and Animal/Veterinary CT Imaging Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Animal/Veterinary MRI Market Analysis And Forecast The Veterinary MRI market was valued at USD 198.8 million in 2021 and is expected to reach over USD 300.0 million by 2030 at a CAGR of 7.3% from 2022 to 2030. Rising usage of this modality by veterinarians in whole-body imaging due to the associated benefits such as high contrast and detailed anatomical tomographic images is expected to provide a growth platform in the coming 5 years. Moreover, rising penetration in orthopaedics, neurologic, and oncologic therapeutic applications will further boost the growth of this market. MRI in ophthalmology is highly investigated in canine fibrosarcoma and feline melanoma cases. It is now widely applied in clinical areas of nasal neoplasm, musculoskeletal diseases, shoulder diseases, elbow dysplasia, ligament injuries, and orbital & eye diseases. In addition, the application of MRI in large animal research is significantly growing. Since MRI does not use ionizing radiation, it is safe in general for pregnant animals majorly during the third or second trimester. Animal/Veterinary CT Imaging Market Analysis And Forecast The global super-resolution microscopes market was valued at USD 161.5 million in 2021 and is expected to grow at a CAGR of 6.7% over the forecast period. The rise in the companion animal population coupled with the growing adoption of pet insurance is anticipated to boost the market growth. Furthermore, an increasing number of veterinary practitioners and technological advancements in the sector are expected to fuel animal/veterinary CT imaging market growth. CT has been widely explored since its first veterinary application for investigating the central nervous system in dogs and cats. In most cases, CT provides valuable images that are not precise in ultrasound or other radiography procedures. CT scans can be used in different species of animals to diagnose lesions, sinuses, jaw & dental arcade, retrobulbar region, skull, joints, and appendicular skeleton. Moreover, several bone diseases are investigated using CT scans as they can image bone curvature, angles, architecture, and thickness. The North American region includes the U.S. and Canada, and it dominated the global market with the highest share of over 45.0% in 2021. This can be attributed to high healthcare costs and rise in the prevalence of obesity among the pet population. Furthermore, a surge in pet insurance claims is anticipated with the growing concern about pets among pet owners. For instance, it was estimated that in the U.S. pet adoption rate was around 2.48% in 2021 with about 4.0 million total pets. Go through the table of content of Veterinary Imaging Instrument Industry Data Book to get a better understanding of the Coverage & Scope of the study. Competitive Landscape Key players operating in the Veterinary Imaging Instrument Industry are – • IDEXX Laboratories, Inc. • Canon Medical Systems Corporation • FUJIFILM Holdings America Corporation • Samsung • Heska Corporation • Butterfly Network, Inc. • Carestream Health • Midmark Corporation • ESAOTE SPA • SOUND Wound Debridement Industry Helps To Revolutionizing Wound Care With Debridement Techniques12/27/2023 Global wound debridement industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.
The global wound debridement industry was estimated at USD 5.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. Wound Debridement Market Report Highlights The global wound debridement market size was valued at USD 4.45 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030. The high incidence of chronic conditions, such as pressure ulcers, diabetic foot ulcers, and other target wounds, the availability of reimbursement in developed economies, and changing lifestyles are anticipated to drive the market. Furthermore, the increased incidences of injuries such as accidents as road accidents, burns, and trauma events across the globe are also anticipated to drive the market. Additionally, the widening base of the geriatric population and increasing initiatives by governments and private organizations to raise awareness regarding wound care treatment are projected to work in favor of the market. Based on region, North America held the dominant market share of 37.87% in 2022. This supremacy can be attributed to the region's well-developed healthcare infrastructure, growing awareness, and the presence of significant important actors. Additionally, the market for wound debridement is anticipated to be driven by an increase in surgical procedures in the North American area. Enzymatic Wound Debridement Market Report Highlights The global enzymatic wound debridement market size was valued at USD 864.24 million in 2022 and is expected to grow at a CAGR of 6.17% over the forecast period. Market demand is rising owing to an increase in the prevalence of chronic diseases, a high number of accidents, and the introduction of technologically advanced products across the globe. Various initiatives being undertaken by researchers and major market players to develop technologically advanced products owing to the rising demand for enzymatic wound debridement products globally are anticipated to contribute to the market growth. Until now, collagenase-based enzymatic wound debridement products have been majorly used for the treatment of chronic and acute wounds and papain-based products have been predominantly used for the treatment of chronic wounds. Since awareness about the use of such products is increasing, several technologically advanced products are being introduced in the market. Collagenase-based enzymatic wound debridement product segment held the largest share in 2022. Collagenase-based ointments, creams, and gels are some of the enzymatic debridement products used for the debridement of necrotic tissue from venous leg ulcers, pressure ulcers, burn wounds, & partial-thickness burns. These products enable rapid healing and are also effective in the treatment of diabetic foot ulcers. Collagenase-based enzymatic wound debridement products are easily available and are commonly used by medical professionals. The rising prevalence of pressure ulcers, diabetic foot ulcers, and venous leg ulcers is anticipated to contribute to segment growth. Order your copy of Free Sample of “Wound Debridement Industry Data Book - Wound Irrigation Systems, Enzymatic Wound Debridement, Maggot Debridement Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Maggot Debridement Market Report Highlights The global maggot debridement market size was valued at USD 11.88 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.2% from 2023 to 2030. The global increase in the incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is one of the major factors contributing to market growth. The biobags segment held the largest revenue share in 2022 in the market overall maggot debridement market. The segment is anticipated to witness significant growth over the forecast period. This is owing to the rising prevalence of chronic wounds and an increasing number of surgeries across the globe. Biobags are comparatively safer to use and provide results in 28 days. It is the first contained biosurgical dressing approved by the Food and Drug Administration (FDA). Wound Irrigation System Market Report Highlights The global wound irrigation systems market size was valued at USD 303.84 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.9% from 2023 to 2030. The demand for wound irrigation systems is on the rise owing to technological advancements, the increasing prevalence of chronic diseases, and the rising number of surgical procedures. The rising prevalence of chronic and acute wounds and the introduction of advanced products are the major factors anticipated to drive the market. The global increase in the incidence of chronic diseases, such as diabetes, cancer, and other autoimmune diseases, is anticipated to fuel the market growth. Factors such as antimicrobial resistance, adoption of unhealthy and sedentary lifestyles, alcohol consumption, and smoking are some of the major factors contributing to the rise in the prevalence of non-communicable diseases. According to the International Diabetes Federation, in 2021 there were about 536.6 million diabetes cases globally, the same source stated that the cases are expected to reach 642.8 million by 2030. Therefore, such factors are expected to surge the demand for the product, thereby propelling the market growth. Competitive Landscape Key players operating in the Wound Debridement Industry are –
Global wound dressing industry data book, pblished by Grand View Research’s is a collection of sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. The global wound dressing industry was valued at USD 61.0 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.5% from 2022 to 2030. Abdominal Pads Report Highlights The global abdominal pads market size was valued at USD 967.9 million in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. The abdominal pad is used as a secondary dressing over a primary dressing such as alginate or hydro fiber and it is made up of highly absorbent material to absorb excess fluid. The market for abdominal pads is anticipated to be majorly driven by the rising cases of burn injuries and the surge in the prevalence of chronic wounds. Moreover, the rise in the number of surgical procedures is further expected to fuel market growth. Burns continue to be one of the most prevalent types of injuries, making up a significant number of trauma cases for hospital emergencies globally, marking a decline in their frequency. Burns also continue to cause high mortality rates and morbidity. According to an article titled, “The Global Macroeconomic Burden of Burn Injuries” published in PRS Journal in October 2021, over nine million people suffer from thermal injuries annually across the world. Among those injured, 90% of mortality occurs in low- and middle-income countries (LMICs). Nearly half of these fatalities take place in the South-East Asian regions with the majority occurring in low and middle-income nations. In India, seven million individuals experience burn injuries annually, resulting in 1.4 lakh fatalities and 2.4 lakh disabled people. Thus, the rising prevalence of burn injuries is fueling the abdominal pads market growth. Medical Adhesive Tapes Report Highlights The global medical adhesive tapes market size was valued at USD 750.9 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030. The rising prevalence of chronic disorders, such as diabetic ulcers, venous leg ulcers, and traumatic wounds, is one of the key factors leading to an increase in the usage of medical adhesive tapes. For instance, according to WHO figures, every year, roughly 1.2 million people die due to vehicle crashes, whereas 20 to 50 million people incur non-fatal injuries. The demand for medical adhesive tapes significantly reduced as a result of the COVID-19 pandemic. Medical adhesive tapes are an essential component of healthcare, but due to an increase in COVID-19 cases, there has been a decline in market demand. Hospitals and clinics were under more pressure to reprofile their patients and give COVID-19 patients priority care as the rate of hospitalization rose. However, players in this industry changed their approaches by deciding to pursue R&D throughout the pandemic and creating cutting-edge technologies to assist in the fight against the virus. Order your copy of Free Sample of “Wound Dressing Industry Data Book - Abdominal Pads, Medical Adhesive Tapes and Super Absorbent Dressings, Medical Tapes & Bandages, Moist Wound Dressing, Surgical Dressing Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Super Absorbent Dressings Report Highlights The global super absorbent dressings market size was valued at USD 99.92 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.7% from 2022 to 2030. The demand for super-absorbent dressings is expected to increase due to an increase in the number of chronic diseases across the globe. For instance, according to the Government of Canada, 44% of Canadian adults have at least one of the ten most common chronic conditions. According to a similar source, 11% of Canadians suffer from diabetes, whereas 8% have cancer. Furthermore, a rise in the geriatric population is one of the major driving factors in the market. For instance, according to the Canadian Institute for Health Information, in 2017, the geriatric population comprised 6.2 million, which was expected to reach 10.4 million by 2037. Therefore, an increase in the number of chronic diseases, along with the growth of the geriatric population, is anticipated to propel the market growth during the forecast period. Super absorbent dressings are designed to minimize the adherence to wounds and manage exudate. These dressings can be used over surgical incisions, burns, lacerations, exudating wounds, or grafts. Thus, an increase in the number of surgical procedures is expected to propel the market growth during the forecast period. For instance, according to OMICS Group Conference, about 51.4 million surgical procedures are carried out in UAE, whereas this number increases to 234 million worldwide. Hence, due to the aforementioned factors, the market is anticipated to grow over the forecast period. Competitive Landscape Key players operating in the Wound Dressing Industry are – • 3M • Paul Hartmann AG • MiMedx • Medline Industries • Smith & Nephew • ConvaTec Group PLC • Integra LifeSciences • B. Braun SE • Molnlycke Health Care AB • Brightwake Ltd. • Lohmann & Rauscher Weight Loss Procedures Industry To Boom As Of Increasing Incidence Of Obesity Across All Age Groups12/22/2023
Weight Loss Procedures Industry Data Book Covers Liposuction Surgery, Bariatric Surgery, Non-invasive Fat Reduction Market. Global weight loss procedures industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. Weight Loss Procedures market was valued at USD 12.1 billion in 2022 and is growing at a CAGR of 10.9% during 2023-2030. Liposuction Surgery Devices Market Report Highlights The global liposuction surgery devices market size was valued at USD 5.4 billion in 2022 and is growing at a CAGR of 12.6% during 2023-2030, according to a new report by Grand View Research, Inc. The rising frequency of men and women who want to be in proper shape and reduce & remove excess fat from their bodies has led to high demand for liposuction surgeries thus driving the Liposuction surgery market. The liposuction procedure is gaining popularity due to the positive influence garnered by it on social media and the scope of better outcomes while reducing costs & minimizing health risks. The growing trend of noninvasive cosmetic procedures and liposuction is expected to witness significant demand. The field of liposuction has observed many new developments based upon advancements in technology, such as ultrasonic-assisted liposuction, Vaser, Smart Lipo laser-assisted liposuction, Slim Lipo, and PAL power-assisted liposuction. Bariatric Surgery Devices Market Report Highlights The global bariatric surgery devices market was valued at USD 5.2 billion in 2022 and is expanding at a CAGR of 7.4% during 2023-2030, according to a new report by Grand View Research, Inc. Factors such as the high obesity rate, the presence of global players, and approvals by the government for non-invasive surgeries are expected to propel the market growth. Obesity is caused due to unhealthy eating habits and physical inactivity. Obesity is increasing not only in the adult population but also in people under 18 years of age. This is owing to physical inactivity, sitting for hours in front of the TV, playing video games, and no outdoor games. In the case of eating habits, people have more inclination towards fast food rather than healthy food. The high prices of bariatric surgeries in the U.S. have increased medical tourism outside the U.S. and in developing countries such as Mexico and India. Order your copy of Free Sample of “Weight Loss Procedures Industry Data Book - Liposuction Surgery, Bariatric Surgery, Non-invasive Fat Reduction Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Non-invasive Fat Reduction Market Report Highlights The global non-invasive fat reduction market size was valued at USD 1.5 billion in 2022 and is growing at a CAGR of 14.6% during 2023-2030, according to a new report by Grand View Research, Inc. The rising involvement of market players in developing and introducing innovative technologies is driving the non-invasive fat reduction market. Other factors like increasing awareness, surging obese population, rise in disposable income, change in lifestyle due to globalization, and increasing demand for fat reduction treatment are expected to boost the market growth. According to the statistics of The Aesthetic Society, non-surgical procedures increased by 44% in 2021. Non-invasive treatments are rapidly replacing invasive surgeries. People are opting more for aesthetic procedures such as skin rejuvenation, fat reduction, and body contouring as the risk associated with these treatments are minor and are gaining a lot of spotlight through various digital platforms. Competitive Landscape Key players operating in the Weight Loss Procedures Industry are – • Long Island Plastic Surgical Group • Nazarian Plastic Surgery • Piedmont Plastic Surgery & Dermatology • Anadolu Medical Center • Quirónsalud Madrid University Hospital • Hermes Clinics • The Ageless Clinic • Manipal Hospitals • Apollo Hospitals • Hospital Samaritano de Sao Paulo • Center of Plastic Surgery & Rehabilitation • Passy Clinic • Your Lipo • NMC Royal Hospital, Khalifa City • Burjeel Specialty Hospital, Sharjah Veterinary Rehabilitation Services Industry | Rehab Is Bringing Animal Wellness To New Heights12/22/2023 Veterinary Rehabilitation Services Industry Data Book Covers Companion Animal, Livestock, Wildlife Animal Market. Global veterinary rehabilitation services industry data book is a collection of market sizing information & forecasts, regulatory data, competitive benchmarking analyses, macro-environmental analyses, and technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. The global market size for veterinary rehabilitation services (companion, livestock, & wildlife) was estimated at USD 792.4 million in 2022 and is anticipated to increase at a CAGR of 11.69% from 2023 to 2030. Companion Animal Rehabilitation Services Market Report Highlights: The global companion animal rehabilitation services market size was valued at USD 499.7 million in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 11.42% from 2023 to 2030. Based on animal type, the market is segmented into dogs, cats, and others. The advancing pet humanization trends, significant pet ownership rates, and an increasing number of surgical admissions for several pet disease conditions, coupled with post-surgery rehab services referred by veterinarians, are some of the key factors driving the market. Furthermore, the growing penetration of pet insurance in developed & developing countries is contributing to substantial market growth. In addition, the increasing number of organizations recruiting volunteer animal rehabilitators is further boosting the market growth. For instance, ‘our companion-animal rescue & sanctuary organization’ in the U.S. offers two different ways for the general public to volunteer in rehabilitating stray companion animals. Furthermore, the increase in training programs for pet rehabilitation and its wide traction among veterinary practitioners and therapists are further unveiling new opportunities in the market. For instance, the American Association of Rehabilitation Veterinarians states that physical rehabilitation is a rapidly growing field in the veterinary industry with growing educational opportunities. Livestock Animal Rehabilitation Services Report Highlights The global livestock animal rehabilitation services market size was valued at USD 151.93 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 11.87% from 2023 to 2030. The market is primarily driven by the rising livestock population in developing countries, growing awareness about the benefits of rehabilitation modalities in livestock medical treatments, and increasing adoption of physical therapy among injured farm animals to accelerate healing. In addition, government-sponsored livestock rehabilitation organizations and foundations are increasing in developing regions, which further propels the growth of the market. As per an analysis report published by the Woodland Park Zoo, certain livestock species, such as goats, are often given exercise therapies such as weight shifting and stretching to heal soreness. The warm or hot water floatation therapies are considered an ideal rehabilitation for cows that have damaged limbs or traumatic injuries. The buoyancy of the water enables animals to support their body weight, thereby enhancing easy movements with relatively lesser pain. To promote mobility & rapid wound healing in small livestock species, underwater treadmills are used in rehabilitation centers. North American region dominated the livestock animal rehabilitation services industry with the largest revenue share of around 30% in 2022. The substantial share is attributed to the large presence of licensed veterinary rehabilitators, the increasing number of veterinary hospitals, farm sanctuaries, & rehab centers, advancing veterinary care services, and the rising adoption of physical therapies for farm animals. Order your copy of Free Sample of “Veterinary Rehabilitation Services Industry Data Book - Companion Animal, Livestock, Wildlife Animal Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Wildlife Animal Rehabilitation Services Market Report Highlights The global wildlife animal rehabilitation services market size was valued at USD 140.78 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 12.43% from 2023 to 2030. With the growing number of people valuing wildlife conservation, the number of volunteer rehabilitators who rescue and protect wounded/injured wildlife animals is also increasing. For instance, according to a study published in March 2022, by the National Library of Medicine, millions of native animals are rescued, rehabilitated, and protected by wildlife rehabilitators each year globally. As the rate of extinction of numerous wild species is accelerating, several countries are increasing their wildlife rescue and rehab facilities, more importantly, to protect endangered species. For instance, Victoria State Government, Australia, grants USD 230,000 for the country’s wildlife rehabilitators as per Wildlife Rehabilitator Grants 2022-30 program. As per the grant, each rehabilitator applicant who holds a valid authorization from the DELWP (Department of Environment, Land, Water, and Planning) is funded up to USD 3,000. Such supportive initiatives by the government are anticipated in boosting the growth of the market. Competitive Landscape Veterinary rehabilitation hospitals and centers are routinely implementing strategic measures such as advancing their infrastructure with newer therapeutic instruments and launching novel service offerings for various animal species. Key players operating in the Veterinary Rehabilitation Services Industry are – • BARC • Essex Animal Hospital • Blue Springs Animal Rehabilitation Center • Triangle Veterinary Referral Hospital About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Skin Diseases Treatment Industry Data Book Covers Actinic Keratosis Treatment, Atopic Dermatitis, Alopecia and Acne Drugs Market. Global skin diseases treatment industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. The following data points will be included in the final product offering in five reports and one sector report overview. Actinic Keratosis Treatment Market Analysis & Forecast The global actinic keratosis (AK) market was valued at USD 6.42 billion in 2022 and is anticipated to witness growth at a rate of 4.20% over the forecast period. Untapped opportunities, the growing prevalence of atopic dermatitis, and the rise in adoption of biologics are anticipated to propel the market growth over the forecast period. Moreover, ongoing product approvals and a surge in product launches are other factors contributing to market growth. For instance, in February 2021, Almirall launched its topical AK treatment in the U.S. In addition, hospitals such as Mount Sinai, Metro East Dermatology, and Skin Cancer Center, among others, offer multiple treatment options for AK. For instance, Mount Sinai group of hospitals offers cryosurgery, topical therapy, chemical peels, and PDT for its management. According to the American Academy of Dermatology Association, more than 40 million Americans develop AK each year and according to the NEWS Medical, the overall rate of AK in the U.S. is estimated to be about 26.5% in males and 10.2% in females. Thus, the prevalence of the disease is higher in men as compared to women. In addition, according to Skin Cancer Foundation, around 58 million Americans have one or more AK. This is the most common precancerous condition to occur on the skin damaged by UV rays. Solar keratosis is an alternative name for AK. If it is not treated in time, then it can develop into SCC, a common type of skin cancer, and it is estimated that around 5% to 10% of AK can develop into SCC. Atopic Dermatitis Market Analysis & Forecast The global atopic dermatitis market was valued at USD 14.19 billion in 2022 and is anticipated to witness growth at a rate of 8.70% over the forecast period. Untapped opportunities, the growing prevalence of atopic dermatitis, rise in the adoption of biologics are anticipated to propel the market growth over the forecast period. Continuous itching of the skin has heightened the adoption rate of topical ointments and creams. For instance, as per the National Eczema Association, 85.8% of people suffering from the condition report daily itching, which makes the adoption of fast-acting topical agents more likely when compared to oral drugs. Increased frequency of hand-washing has increased the appearance of dry and cracked skin in atopic dermatitis patients making them susceptible to infections. The increased number of hand eczema cases is creating an opportunity for the market players to develop ointments and creams with moisturizer bases to capture this untapped opportunity. Topical corticosteroids are the first-line treatment for Atopic Dermatitis (AD). They work by mimicking natural hormones in the body and suppressing the immune system. Corticosteroids are available in various potencies and administered on the basis of the severity of the disease. The introduction of biologics has caused a paradigm shift in the therapeutic setting for AD. Biologics was the largest revenue-generating segment, which is attributed to increased penetration and high usage of the FDA-approved drug Dupilumab. The novel mechanism of target specificity provided the drug offers it a competitive edge in the market. Furthermore, the high price of this drug is likely to accelerate segment growth. However, the others segment is anticipated to witness the highest growth over the forecast years owing to the presence of JAK inhibitors in the pipeline. Order Free Sample Copy of “Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” published by Grand View Research Alopecia Market Analysis & Forecast The global alopecia market was valued at USD 8.19 billion in 2022 and is anticipated to witness growth at a rate of 8.74% over the forecast period. The significant growth rate can be attributed to the increased number of patients opting for dermatological drugs for the treatment of alopecia and the increasing interest of major pharmaceutical giants in the development and commercialization of novel drugs. In June 2022, FDA approved baricitinib for the treatment of alopecia areata severe cases. Prior to the approval, the treatment was limited to the areas of hair loss, which limited the treatment scope. Smaller players such as Concert Pharmaceuticals are focusing only on developing treatments for alopecia with two successful phase III trials and the drug is projected to launch between 2023-2024. Unmet need and huge revenue generation opportunity is attracting players to the market. The growing prevalence of alopecia is one of the crucial factors driving market growth. As per the American Hair Loss Association, it was stated that over 95% of hair loss in males is triggered by androgenetic alopecia. The occurrence of hair loss in men increases proportionately with age. Based on the report published by the International Society of Hair Restoration Surgery, it was estimated that nearly 40% of men encounter some degree of hair loss by 35 years of age, 65% at 60 years, 70% at 80 years, and 80% at the age of 85. Acne Drugs Market Analysis & Forecast The global acne drugs market size was valued at USD 8.43 billion in 2022 and is anticipated to witness growth at a rate of 4.74% over the forecast period. The rising importance of aesthetics among the population, unhealthy lifestyle, and increased preference for pharmaceutical drugs over OTC cosmeceutical treatments is driving the market growth. Acne impacts as many as 85% of the population aged 12-24 years and the number is as high as 50 million each year in the U.S. The global prevalence rate for acne is 9.4% which creates a high demand for acne-associated therapeutic products. The Pandemic hampered market growth for acne drugs attributable to limited access to dermatologists, thereby leading to a significant decline in the number of patients receiving prescription drugs. However, the number of patients increased post-pandemic with the rise in patient visits. High demand for over the counter and topical treatments is significantly influencing the market growth with an increase in awareness regarding the usage of pharmaceutical products. The escalating number of competitors focusing on the launch of products in the segment is intensifying the competition. For instance, in March 2022, Galderma announced the launch of an acne vulgaris treatment topical cream. The prescription of a multi-step regimen is common for acne; however, this drug allows once-daily treatment, thus making its adoption easier. Go through the table of content of skin diseases treatment industry data book to get a better understanding of the Coverage & Scope of the study. Key players operating in the skin diseases treatment industry are – • Pfizer Inc. • AbbVie Inc. • Sun Pharmaceutical Industries Ltd. • GSK plc. • Amgen Inc. • Eli Lilly and Company • UCB • Novartis AG • Johnson & Johnson • Galderma S.A • AstraZeneca plc In Vitro Diagnostics And IVD Quality Control Industry Trends and Innovation: Guiding the Future12/21/2023
In vitro diagnostics and IVD quality control industry data book covers in vitro diagnostics (IVD) and IVD quality control market. Global In Vitro Diagnostics and IVD quality control industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, volumetric analyses, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. The following data points will be included in the final product offering in two reports and one sector report overview. In Vitro Diagnostics (IVD) Market Analysis & Forecast The global in vitro diagnostic market size was valued at USD 111.67 Billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 0.2 % from 2022 to 2030. IVD renders accurate & effective results and has indispensable applications in the field of disease diagnosis. Eventually, quality control services have become requisite in accredited medical or clinical laboratories. In vitro diagnostics shows significant potential for growth driven by an aging global population that requires accurate diagnosis, increased demand for targeted cancer therapies supported by Companion Diagnostic (CDx) devices, and rising demand for infectious diseases diagnostics due to frequent viral/bacterial outbreaks such as COVID-19. In addition, NGS-based genetic prenatal tests are becoming more common, and adoption of these tests is rising due to their low false-positive rates. Hence, FDA recently issued guidance to improve oversight of test quality, accuracy, safety, and medical benefit. Key players such as Illumina, Inc. have NGS-based prenatal screening tests that allow detection of common abnormalities like Down syndrome. Furthermore, the number of people suffering from congenital heart disease is increasing, requiring medical professionals to develop IVD tools for accurate diagnoses. According to CDC, congenital heart defects are the most common birth defects in the U.S., affecting approximately 1% of births every year. The use and demand of Point-of-Care (PoC) tests and devices are rising owing to increased demand for rapid identification of diseases in close proximity to patients to facilitate faster decision-making. This trend is pushing manufacturers to launch small, transportable, fast, and easy-to-use instruments, making use of these instruments easier in non-laboratory settings. For instance, in July 2021, QuantuMDx announced the launch Q-POC system, which offers rapid PoC molecular diagnostics advantageous for settings, such as ICUs, clinics, and birthing centers. IVD Quality Control Market Analysis & Forecast The global in vitro diagnostics quality control market size was estimated at USD 1.12 Billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 2.0% from 2022 to 2030. In IVD quality control, immunochemistry led the global market in 2021 and accounted for a revenue share of more than 35.00%. Key applications of the immunochemistry include detection of infectious microorganisms, such as viruses, bacteria, and fungi, by detecting the presence of their toxins and coat antigens. Diagnostics laboratories are in demand owing to the increasing prevalence of diseases such as infectious diseases, cardiovascular conditions, and diabetes. To meet the industry demand, many private and public laboratories are undergoing accreditation procedures, which is creating a surge for IVD quality control measures. As of May 2022, the quality standards of 330,000 laboratories in the U.S. are regulated under the Clinical Laboratory Improvement Amendments (CLIA) by the CMS, making quality management crucial. Order Free Sample Copy of “In Vitro Diagnostics And IVD Quality Control Industry Data Book - In Vitro Diagnostics & IVD Quality Control Market Size, Share, Trends Analysis, And Segment Forecasts, 2022 - 2030” published by Grand View Research Key players operating in the In Vitro Diagnostics And IVD Quality Control Industry are – • ABBOTT • BIOMÉRIEUX SA • BIO-RAD LABORATORIES, INC. • BECTON, DICKINSON AND COMPANY • SIEMENS HEALTHINEERS AG • QIAGEN • QUIDEL CORPORATION • F. HOFFMANN-LA ROCHE LTD. • SYSMEX CORPORATION • CHARLES RIVER LABORATORIES • QUEST DIAGNOSTICS • AGILENT TECHNOLOGIES, INC. • DANAHER CORPORATION • Bio-Rad Laboratories, Inc. • Thermo Fisher Scientific, Inc. • Sero AS. • Sun Diagnostics, LLC • Ortho Clinical Diagnostics, Inc. • Randox Laboratories Ltd • Helena Laboratories Corporation • SeraCare Life Sciences, Inc. • Technopath Clinical Diagnostics |
Archives
December 2023
Categories |